Microvascular endothelial cells from rat and guinea pig fat pads were shown to bind diamine oxidase (DAO) activity when incubated with soluble extracts of placenta (33 DAO U/mg of placenta) and a purified placental enzyme preparation (94 U/ gg of protein). The extent of binding was dependent on the concentration of enzyme activity and tissue. Saturation of binding sites with 5,000 U of DAO/ml resulted in levels of bound activity (up to 11-13 U/mg of endothelial cells) in excess of that observed in all tissues except placenta. Scatchard plots suggested that there were at least two DAO binding sites (apparent K., 92 and 2,450 U/ml). Although the same cell preparations bound 125I-labeled lipoprotein lipase (LPL), the presence of LPL on the endothelial cell surface did not interfere with the binding of DAO activity except when cells were exposed to high concentrations of LPL. Alternatively, bound DAO activity was partially displaced (up to 33%) only with high concentrations (30 zg/ml) of LPL. DAO activity may thus be bound to at least two populations of sites, one of which may bind LPL. Both enzymes, however, were displaced by heparin (0.05-5 U/ml) and DAO binding was impaired by prior treatment of cells with proteolytic and glycosaminoglycandegrading enzymes. The demonstration of DAO binding to vascular endothelial cells provides a further example of the ability of these cells to bind enzymes at their surface and thereby act on biologically active substances in the circulation.
Introduction
The enzyme diamine oxidase (EC 1.2.6) (DAO)' catalyzes the deamination of histamine and diamines such as putrescine and cadaverine (1, 2) . This enzyme plays a major role in histamine degradation in the rat and some other species (3, 4) . DAO activity is produced in particularly high amounts by the maternal placenta (5, 6) , and this results in large increases in enzyme activity in plasma (e.g., [7] [8] [9] [10] [11] (unpublished data) during pregnancy. In nonpregnant animals, the enzyme is released upon injection of heparin into the circulation of humans (12) (13) (14) and the rat, rabbit (15) , and guinea pig (15, 16) . Inasmuch as this release is apparent within 20 s (14) and because DAO activity is present in or on microvascular endothelial cells from rat and guinea pig (17) , we have examined the possibility that heparin might act by displacement of DAO from vascular endothelial cells. By analogy, lipoprotein lipase (LPL) activity (EC 3.1.1.3) is released along with DAO activity into the circulation by heparin (13, 14) , is bound to cultured endothelial cells from bovine pulmonary artery (18) and calf aorta (19) , and is displaced from these cells by heparin from sites believed to contain heparan sulfate-like moieties (18) (19) (20) .
Here we describe studies on the adherence of DAO activity and LPL to isolated rat and guinea pig microvascular endothelial cells (17) and the displacement of the two enzymes by heparin. We have defined the characteristics of DAO Piebald guinea pigs, 500-1,000 g, were obtained from Division of Research Services, National Institutes of Health (Bethesda, MD). Drugs and reagents were obtained from the following sources: media (Grand Island Biological Co., Grand Island, NY); cystalline bovine serum albumin (Pentex bovine albumin, Miles Laboratories, Elkhart, IN); glucose, L-glutamine, bovine serum albumin-fraction V (Sigma Chemical Co., St. Louis, MO); collagenase type II, soybean trypsin inhibitor (Worthington Biochemical Corp., Freehold, NJ); heparin sodium, 1,000 USP U (8.33 mg/ml), (The Upjohn Co., Kalamazoo, MI); Percoll and density marker beads (Pharmacia Fine Chemicals, Piscataway, NJ); dioctyl-and dibutylphthalate (ICN Pharmaceuticals, Plainview, NY).
For the isolation and for studies with microvascular endothelial cell preparations, the following solutions were used: solution A contained Eagle's minimum essential medium amino acid solution (X 50), 50 ml/liter; glucose, 14 mM; L-glutamine, 2 mM and bovine serum albumin, 0.4% wt/vol in Dulbecco's phosphate-buffered saline (pH 7.4) (17) . Supplemented Dulbecco's modified Eagle's medium (DME) contained 5.5 Enzyme preparations and extracts. Human (postpartum) and rat (1 5-d term) placentas were stored at -20'C and extracts were prepared daily as required. Tissues were homogenized in 11 vol of supplemented DME. The homogenates were centrifuged (2,000 g for 10 min) and the supernatant fractions were collected. These extracts were diluted in supplemented DME (40C) as required.
DAO was purified from Sprague-Dawley rat placenta by modification of previously published procedures (21, 22) . DAO activity in a 1:3 (wt/vol) homogenate of rat placenta (100 g) was purified 100-fold by adsorption onto Sepharose-cadaverine and elution with heparin exactly as described (22) . The enzyme activity was further purified (threefold) by passage through a 1 X 22-cm column of concanavalin A bound to Sepharose 4B and elution with 0.6 M mannose. This (pH 7.4) . '251I-LPL was prepared by the lactoperoxidase procedure (24, 25) and purified by chromatography on Sepharose-heparin columns equilibrated in 20 mM Tris-chloride, 0.1% Triton X-100, 20% (wt/vol) glycerol, 0.1% (wt/vol) bovine serum albumin (pH 7.4), and elution with a gradient of 0-2 M sodium chloride in the same medium. Before use, the enzyme preparations (0.5-1.0 ml) were dialyzed (2 h, 40C) against two changes of supplemented DME. The enzyme preparations were diluted in supplemented DME with 0.1% wt/vol Pentex bovine albumin. Specific activity of 25I-labeled LPL preparations ranged from 1.6 to 4.5 nCi/ng of protein.
Preparation ofmicrovascular endothelial cells. Earlier protocols for the preparation of these cells from rat epididymal and guinea pig epididymal-perirenal fat pads (17) were modified by substituting Percoll for serum albumin gradients in the final separation step. Up to this step the procedures were exactly as described previously. Percoll gradients were prepared in 40-ml tubes by centrifugation (30,000 g for 60 min in an ultracentrifuge [model L8-55; Beckman Instruments, Inc., Fullerton, CA] with an angle rotor head) of a 1 + 1-part mixture of Percoll with solution A described above. Samples (4 X 2 ml) of the cell suspensions were carefully layered on top of four Percoll gradients. The tubes were centrifuged (model TJ-6 [Beckman Instruments, Inc.] in a swinging bucket head) at 1,000 gfor 10 min. From each tube, a band (density 1.048 g/ml) of endothelial cells was carefully removed from a lower layer of erythrocytes and transferred to a plastic tube before dilution with 10 ml of supplemented DME. Cells were recovered by centrifugation (100 g for 3 min), pooled, and then resuspended in the same medium to give I mg of tissue/50 ul of suspension unless indicated otherwise. All centrifugations were at 4VC.
All preparations were assayed for protein (17) . Cell viability was assessed by the fluorescein diacetate/ethidium bromide dye exclusion technique (26) . As in previous studies (17) 370C in a total volume of 100 Ml. The amounts of tissue and enzyme preparation and period of incubation were as noted in text and figure legends. The mixture was centrifuged (500 g for 3 min)2 to terminate the reaction. 80 1M of the supernatant fraction was saved for DAO or LPL assays and the remainder was removed carefully to avoid disturbing the cell pellet. The cell pellet was washed twice in 100 Ml ice-cold supplemented DME before resuspension in 100 Ml of the same medium. To minimize cell breakage, cells were resuspended by gentle aspiration through a soft 2. Conditions for centrifugation were chosen to ensure minimal cell breakage (<10% loss of cell protein or cell viability as determined by vital stains) and maximal recovery of cells. polyethylene 3-ml transfer pipette. The washing procedure was used exclusively in the present studies in that this procedure permitted recovery of cells for further incubation (see following section). Enzyme activity recovered from the cell pellet by washing was otherwise similar to that recovered from cells centrifuged through a mixture of dioctyland dibutylphthalate (40 + 60 parts) at 10,000 g for I min. The residual DAO activity appeared to be tightly bound as discussed later. The final cell suspension was disrupted by sonication or where indicated cells were left intact. Sonicated or intact cell suspensions and original supernatant fractions were assayed immediately for DAO activity, which is otherwise destroyed by freezing and thawing, by measurement of tritium release from [, (27) . Values for kinetics of binding were based on activity recovered from pellets and medium. Loss of enzyme activity (36±9%; mean±SEM of five preparations) occurred when low (<20 U/ml) but not high (>50 U/ml) concentrations of DAO activity were incubated at 370C for 30 min in the absence or presence of endothelial cells. For this reason, DAO activity was assayed in both the supernatant and cellular fractions to monitor for loss of enzyme activity.
Binding of '25I-LPL was determined by the same procedure except that incubations were done at 220C and 0.1% wt/vol bovine serum albumin was added to the supplemented DME. Incubations contained Displacement of bound DAO activity or '25I-LPL. Endothelial cell preparations (I mg in wet weight) were incubated with LPL or DAO activity (total volume, 100 1l) for 30 min as described in the previous section. The cells were recovered and washed once with 100 M1 of supplemented DME and resuspended in 50 Ml of the DME. For these steps cell suspensions were centrifuged at 500 g for 3 min. Heparin, DAO, or LPL preparation was added in the amounts indicated and the volume of suspension was adjusted to 100 ul with medium. The mixtures were then incubated (370C for DAO studies, 220C for LPL studies) for 30 min or as indicated. The cell fraction (after two washes) and medium were collected and assayed for DAO activity or 1251 as described above.
Treatment of endothelial cells with proteolytic and glycosaminoglycan-degrading enzymes. Isolated endothelial cell preparations (I mg in wet weight) from rat fat pads were incubated (370C) in the absence or presence of various concentrations of the indicated enzyme preparation for 5 or 3 min in 0.5 ml of DME. Ice-cold medium (I ml) was then added to quench the reaction and the tubes were immediately centrifuged (500 g for 3 min). The cell pellet was recovered, washed once with DME, and resuspended in 0.1 ml of DME which contained 500 U of DAO activity/ml. The cell suspension was incubated (370C) for 30 min and the amount of bound DAO activity was determined as described in previous paragraphs.
Expression of enzyme activities and experimental results. 1 U of DAO activity is equivalent to 1 pmol of histamine deaminated/h in the presence of 10-7M histamine (27) . In studies of kinetics of DAO binding, a mol wt of 97,000 and purity of 85% (see subsection Enzyme preparations and extracts) was assumed. 1 U of LPL activity is defined as 1 gmol of fatty acid released/min at 220C. Previous studies have indicated that LPL catalytic activity (or the ability of LPL to bind to heparin or to be cleared from plasma upon injection into rats) is not measurably reduced by iodination (25) . Values are expressed as mean or mean±SEM for the number (n) of experiments (i.e., different cell preparations) or determinations (same cell preparation) indicated. Tests for statistical significance were by the two-tailed t test. Curve fitting of data was done through the MLAB program (28) . For data shown in Fig. 6 , curve fitting for one or the sum of two or three MichaelisMenten components was tested. Inasmuch as the data did not allow discrimination between fit of two or three components, calculations were based on an assumed two-component system.
Results
DAO binding: preliminary studies with placental extracts. Both the rat and guinea pig microvascular cell preparations bound DAO activity present in rat and human placental preparations (Table I ). In the presence of low DAO activity and 1 mg of endothelial cell preparation the percentage of DAO activity bound ranged from 16.4±1.2 (n = 6, with 20 DAO U/ml) to 28±4.2 (n = 3, 1 DAO U/ml). Repeated washing of the cells with '100 ,1 of ice-cold medium removed <10% of the bound DAO activity at each wash. Most of this loss was attributable to incomplete recovery or breakage of cells because there was a similar loss of cell protein. Binding was apparent at 40C and 370C and at both temperatures equilibrium was reached by 5-15 min. Subsequently, there was some decrease in the amount of bound activity at 370C not at 40C (Fig. 2) . Although some of this decrease may have been due to inactivation of DAO activity (see Methods) small decreases were still evident when bound DAO activity was expressed as the percentage of total activity recovered from cells and medium. Binding was observed with microvessel preparations obtained from fat pads of two strains of rats as well as guinea pigs (Fig.  3) . The enzyme activity bound was related to concentration of enzyme activity (Fig. 3 A) and amount of tissue (Fig. 3 B  and C) . Saturation of binding was not achieved in the presence of up to 1,000 U of DAO activity/ml of medium (a representative experiment is shown in Fig. 3 A) . At this level of enzyme activity cell pellets for all experiments (n = 4) contained 7.7±1.6 DAO U/mg of tissue (0.31±0.07 U/tg of protein).
Binding did not appear to interfere with the catalytic activity of enzyme. DAO activity as measured in intact cells was not significantly different from that in sonicated rat endothelial cell suspensions.3 All of the DAO activity (104±7% of activity added; n = 9) could be recovered from intact cell pellet and medium in incubations containing >50 DAO U/ml. Displacement of DAO activity by heparin. With cell preparations previously treated with placental extracts, bound DAO activity was released rapidly into the medium in the presence of 40 ug of heparin/ml (5 U/ml) (Fig. 4 A) . Release was observed with as little as 0.2-0.4 Mg of heparin/ml (0.025-0.05 U/ml) and near-maximal release was observed with 8 jug of heparin/ml (Fig. 4 B) .
Kinetics of binding of DAO activity: studies with purified placental enzyme preparations. With purified preparations of enzyme DAO binding occurred at 370C and at a slightly slower rate at 49C. Binding was near-maximal by 30 min (Fig.  5) . Saturation of binding was approached with levels of activity above 5,000 U of DAO activity/ml to yield cell pellets containing 0.46-0.62 DAO U/Mg of tissue protein (-1I1-13 U/mg of tissue). Scatchard plot of the data (Fig. 6 ) was consistent with binding to at least two classes of sites, one of which had a high affinity for DAO with a dissociation constant K1 of 92±51 U/ml (-9 nM) and a value for maximum binding (n1) (20) , is thought to attach to heparan sulfate or similar material (18-20, 35, 36) If endothelial cells do, indeed, bind DAO in the intact animal, the DAO could serve useful functions under these conditions. The major substrates of DAO, histamine and putrescine, are biologically active. Small increases in plasma histamine, for example, produce marked changes in cardiovascular functions and larger increases result in anaphylactic shock (39) . Histamine does not readily penetrate into cells, but it is largely metabolized upon a single passage across most vascular beds (39) . Degradation of histamine at extracellular sites on the endothelial cell would provide an efficient mechanism for clearing histamine from the circulation. Putrescine and related polyamines are produced in tissues undergoing rapid growth or cell division and the uniquely high DAO activity in placenta (40) , intestinal mucosa (41, 42) , and thymus stroma (43) is thought to be associated with the high production of these amines in fetus, intestinal mucosal cells, and thymocytes. In the intestine, DAO is synthesized in the villus cells but then appears to be transported to heparinsensitive binding sites. Although these sites were not identified the intestinal vasculature was suggested as one possible location (41) . At such a location DAO may serve a protective function in preventing leakage of amines from the intestine into the circulation. As the present studies demonstrate after binding of DAO or LPL to endothelial cells, catalytic activities are not impaired or rapidly destroyed.
